Federated Hermes Municipal Securities Income Trust has filed an update with the SEC, confirming that its prospectuses and statements of additional information remain unchanged. This filing is significant as it indicates the company's adherence to regulatory requirements, ensuring that investors have access to consistent and reliable information.
The filing, made on October 30, 2026, under Rule 497(j) of the Securities Act of 1933, certifies that the definitive forms of prospectuses dated October 31, 2026, do not differ from those previously filed. This consistency is crucial for maintaining investor confidence and ensuring transparency in the municipal securities market.
Background
Federated Hermes Municipal Securities Income Trust, with a Central Index Key (CIK) of 0000866700, operates within the investment sector. The trust specializes in municipal securities, providing a range of funds including the Federated Hermes Ohio Municipal Income Fund and the Federated Hermes Pennsylvania Municipal Income Fund. The company is based in Warrendale, Pennsylvania, and is known for its focus on municipal income investments.
What the Filing Says
The recent filing states, "the above-named Registrant hereby certifies that the definitive forms of Prospectuses and Statements of Additional Information dated October 31, 2026, do not differ from the forms of Prospectuses and Statements of Additional Information contained in the Registration Statement for the Funds which was electronically filed." This confirmation is part of their compliance with SEC regulations.
Impact
This update may affect investors and stakeholders in Federated Hermes Municipal Securities Income Trust, ensuring they receive consistent information regarding the trust's offerings. Additionally, the filing reflects the company's commitment to regulatory compliance, which could influence investor perceptions and trust in the municipal securities market.
What's Next
The filing does not say what happens next.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






